key: cord-0290468-79kip39f
authors: Pereira, A.; Bes, T. M.; Velho, M.; Marques, E.; Jannes, C.; Ramos Valino, K.; Dinardo, C. M.; Costa, S. F.; Duarte, A. J.; Santos, A. R.; Mitne-Neto, M.; Pestana, J. M.; Krieger, J. E.
title: Genetic risk factors and Covid-19 severity in Brazil: results from BRACOVID Study
date: 2021-10-07
journal: nan
DOI: 10.1101/2021.10.06.21264631
sha: 60d62f103b7c9e14f8b62d3517435fd0d0c1af52
doc_id: 290468
cord_uid: 79kip39f

The Covid-19 pandemic has changed the paradigms for disease surveillance and rapid deployment of scientific-based evidence for understanding disease biology, susceptibility, and treatment. We have organized a large-scale genome-wide association study in Sars-Cov-2 infected individuals in Sao Paulo, Brazil, one of the most affected areas of the pandemic in the country, itself one of the most affected in the world. Here we present the results of the initial analysis in the first 5,233 participants of the BRACOVID study. We have conducted a GWAS for Covid-19 hospitalization enrolling 3533 cases (hospitalized Covid-19 participants) and 1700 controls (non-hospitalized Covid-19 participants). Models were adjusted by age, sex and the 4 first principal components. A meta-analysis was also conducted merging BRACOVID hospitalization data with the Human Genetic Initiative (HGI) Consortia results. BRACOVID results validated most loci previously identified in the HGI meta-analysis. In addition, no significant heterogeneity according to ancestral group within the Brazilian population was observed for the two most important Covid-19 severity associated loci: 3p21.31 and Chr21 near IFNAR2. Using only data provided by BRACOVID a new genome-wide significant locus was identified on Chr1 near the genes DSTYK and RBBP5. The associated haplotype has also been previously associated with a number of blood cell related traits and might play a role in modulating the immune response in Covid-19 cases.

Abstract: 30

The Covid-19 pandemic has changed the paradigms for disease surveillance and rapid 31 deployment of scientific-based evidence for understanding disease biology, susceptibility, 32 and treatment. We have organized a large-scale genome-wide association study in Cov-2 infected individuals in Sao Paulo, Brazil, one of the most affected areas of the 34 pandemic in the country, itself one of the most affected in the world. Here we present the 35 results of the initial analysis in the first 5,233 participants of the BRACOVID study. 36

We have conducted a GWAS for Covid-19 hospitalization enrolling 3533 cases 37 (hospitalized Covid-19 participants) and 1700 controls (non-hospitalized Covid-19 38 participants). Models were adjusted by age, sex and the 4 first principal components. A 39 meta-analysis was also conducted merging BRACOVID hospitalization data with the 40 Human Genetic Initiative (HGI) Consortia results. 41 BRACOVID results validated most loci previously identified in the HGI meta-analysis. 42

In addition, no significant heterogeneity according to ancestral group within the Brazilian 43 population was observed for the two most important Covid-19 severity associated loci: 44 3p21.31 and Chr21 near IFNAR2. Using only data provided by BRACOVID a new 45 genome-wide significant locus was identified on Chr1 near the genes DSTYK and 46 RBBP5. The associated haplotype has also been previously associated with a number of 47 Introduction 5 In our main analysis, we observed one genome-wide significant locus that reached 115 the pre-defined genome-wide significant level of 5 x 10 -8 (Figure 1 ). We also observed 116 four additional loci that reached the pre-defined p-value threshold of 1 x 10 -6 ( Table 2  117 and Supplementary Figure 1 Specifically, both loci at 3p21.31 and Chr21 near IFNAR2 previously associated with 127 hospitalization need on HGI B1 analysis were nominally significant in our study with the 128 same directionality of effect. We have also compared our results to those described by 129 HGI B2 analysis. We have observed significant associations in all previously described 130 genome-wide loci but for the one on chr9, near the ABO locus (Supplementary File 3) . 131

In addition to looking for replicated signals within our results, we ran two meta-132 analyses between BRACOVID hospitalization need and HGI B1 and B2 analysis. Adding 133 our results to those provided by HGI B1 analysis disclosed a genome-wide association 134 signal on chr6 that was only previously seen on the HGI B2 analysis, strengthening the 135 confidence that this locus is indeed associated with Covid-19 severity (Supplementary 136 File 4 and Supplementary Figure 4) . 137

Our results meta-analyzing BRACOVID summary statistics with HGI B2 results 138 The newly identified genome-wide significant locus near DSTYK was not 152 observed as significantly associated in our HGI meta-analysis. By comparing the local 153 association structure at the DSTYK locus, it is interesting to note that HGI B2 results also 154 suggest a sub-genome-wide significant association at the same region (Figure 2A and B) . 155

However, albeit in the same recombination interval, there is no significant colocalization 156 of the two genetic association structures, suggesting (1) the existence of more than one 157 causal variants within this region or (2) that different LD structures among human 158 populations may be confounding the association pattern at this locus. 159

To explore these scenarios, we have first analyzed the local association structure 160 within the Brazilian sample stratifying by different degrees of European, African, and 161 Native American genetic ancestry among participants. Curiously, although the signal is 162 shared among the 3 groups, the strongest association signal was observed among the 163 Brazilian individuals with high European genetic ancestry ( Figure 2C ). In addition to this, 164 we have studied the pairwise LD between the most associated SNV in the Brazilian 165 analysis (rs11240388), and the most associated SNV in HGI B2 analysis (rs9661015). 166

Strikingly different world-wide pairwise LD patterns are observed among these 2 167 markers ( Figure 2F , https://ldlink.nci.nih.gov/). In our sample, the R-square between the 168 two markers was 0.32 for participants with high European ancestry, and 0.11 for 169 participants with high African ancestry. 170

Using only individuals with high European ancestry from our Brazilian dataset we 171 delineated the associated haplotype boundaries between chr1:205131352 and 172 chr1:205210329, defining a haplotype of approximately 79Kb. Looking into the 173 haplotype structure of markers part of the associated haplotype we did not observe a 174 significant difference in their pairwise LD structure among Brazilians with high 175 European or high African ancestry. Using rs11240388 as a tag-SNP for our risk 176 7 haplotype, we defined world-wide allele frequencies for the risk haplotype ( Figure 2G , 177 https://popgen.uchicago.edu/ggv/). In our own sample, the frequency of the G allele (risk 178 allele) was 48% for the entire sample, 42% in Brazilian individuals with high European 179 ancestry and 59% in Brazilian individuals with high African ancestry. Despite having 180 increased frequency in Brazilian individuals with high African ancestry, and as expected 181 from the stratified local association plots, the haplotype was only significantly associated 182

with Covid-19 severity in Brazilian individuals with high European genetic ancestry. 183

Taken together these results suggest that the causal variant responsible for the association 184 is present in a 79Kb haplotype derived from European populations. 185 186 rs11240388 is also associated with several blood cell traits and with DSTYK and 187

Exploring the genomic annotations for the newly observed locus associated with 190

Covid-19 hospitalization we used rs11240388 as a proxy of the risk haplotype for it is in 191 complete LD with all the markers of the 79Kb haplotype. Rs11240388 is located at 192 chr1:205208489 within the DSTYK gene region. The region appears to be delimited by a 193 recombination region spanning the genes CNTN2, TMEM81, RBBP5, DSTYK, and 194 TMCC2 and harbors several GeneHancer regulatory elements, most notably for CNTN2, 195 DSTYK and TMCC2 ( Figure 3A ). Querying the MR-base database for other phenotypes 196 previously shown to be associated with rs11240388, we observed 69 traits ( Figure 3B ). 197

Of particular interest to Covid-19 biology are blood cell related traits and lung associated 198 traits (Supplementary File 6). 199

Next, we explored the association structure between rs11240388 and GTEx gene 200 expression levels in all tissues and for all genes within the region ( Figure 3C ). Results 201 from GTEx suggest that rs11240388 is an eQTL in several tissues for CNTN2, 202 TMEM81, RBBP5 and DSTYK. Colocalization analysis between GTEx association 203 results and BRACOVID association results confirmed a significant colocalization for 204 these genes in several different tissues, suggesting that the association between the 79Kb 205 risk haplotype and Covid-19 severity might be mediated through gene expression 206 modulation in the genes located in this genomic region ( Figure 3D ). Finally, we tested all 207 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.06.21264631 doi: medRxiv preprint pair-wise possibilities for colocalization: BRACOVID signal, the 69 associated traits for 208 the same region, and all GTEx gene-tissue results with significant colocalization (higher 209 than 0.7) with BRACOVID (Supplementary Figure 5) . This analysis provides several 210 potential intermediate mediators that could explain the association between the identified 211 risk haplotype and Covid-19 severity ( Figure 3E ). 212 213 Discussion 214

Covid-19 has been a world-wide pandemic for more than one year. The disease 215 has killed more than 4 million individuals and has de-stabilized entire health systems as 216 well as the world economy (2,9,10). One striking characteristic of the disease is the large 217 inter-individual variability regarding its severity, ranging from asymptomatic to fatal. 218

Although several identified factors influence disease severity, predicting the overall 219

Covid-19 outcome in a particular individual remains a challenge (3-5). 220

Since the beginning of the pandemic, several groups worldwide have joined 221 efforts to uncover host factors. The Host Genetic Initiative (HGI) included researchers 222 and samples from different parts of the globe to focus on the inter-individual variability 223 in disease presentation (8) and outcomes and the BRACOVID is currently the largest 224 such effort in Latin America. 225 BRACOVID was designed to compare individuals with mild or asymptomatic 226

Covid-19 with those with severe Covid-19 requiring hospitalization. This contrasts with 227 most genetic studies on host determinants of Covid-19, that use individuals from the 228 general population as their main control group. As such, BRACOVID has a more specific 229 study protocol aimed at identifying host genetic determinants of disease severity, and not 230 susceptibility. 231

The results here presented replicate most, but not all, previously reported genome-232 wide significant loci associated with Covid-19 severity. These came from 3 prior 233 publications: The Severe Covid-19 GWAS Group , GenOMICC and HGI (6) (7) (8) . It is 234 interesting to note that despite the large sample sizes, none of these prior studies have in 235 fact compared individuals with mild versus severe Covid-19. As such, our results confirm 236 some of the initial results regarding Covid-19 genetic determinants in a more diverse 237 population and, most importantly, within a study design to differentiate between markers 238 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; 9 of susceptibility to infection and predictors of severity. Also of importance, although 239 BRACOVID has participated in the meta-analysis of both GenOMICC and HGI, due to 240 the analytical plan of these two prior publications, the contrast used by BRACOVID was 241 not the one presented here. Specifically, in both GenOMICC and HGI, BRACOVID 242 summary statistics were obtained by comparing hospitalized Covid-19 individuals with 243 individuals from the general Brazilian population (the last group, not included in the 244 present analysis) on what is called the HGI B2 analysis. Even in this latter situation, 245 BRACOVID sample of hospitalized individuals used in the last version of HGI analysis, 246 the one used in our meta-analysis with HGI B2, was of only 853 individuals, in contrast 247 to the more than 3,500 hospitalized participants used in the present report. 248

Besides the importance of showing replications to previously identified loci in an 249 admixed population, understanding loci that do not replicate might also be important in 250 the follow-up efforts to identify population specific determinants of Covid-19 severity. 251

One of the loci that was not replicated in our analysis is the association signal initially 252 identified in the ABO locus. Our results, together with the verification of intense 253 heterogeneity in signal described by HGI, suggest that the association initially described 254 at this locus may be due to confounding by population structure or other higher order 255 effects. 256

We have observed a new genome-wide significant locus associated with Covid-19 257 in our population. It is comprised by a 79Kb haplotype located on chromosome 1 near the 258 DSTYK gene. The association signal in our sample was only observed in individuals with 259 high European ancestry and was not described by previous studies, suggesting it might 260 harbor a population specific risk allele or haplotype. Indeed, leveraging data from the 261 1000G project (11), we observed great inter-population differences in the haplotype 262 frequency (although an apparently constant LD structure in the region among human 263 populations). 264

Leveraging data from GTEx we were able to associate this haplotype with gene 265 expression levels of at least 5 genes: DSTYK, TMEM81, RBBP5, CNTN2 and TMCC2. 266 In addition, exploring prior publicly available GWAS data we found significant 267 associations between the identified risk haplotype and 69 different traits (8). From these, 268 using colocalization analysis, we have observed significant colocalization between 269 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. CoV-2 PCR test among health professionals or the general population. 296

After signing an informed consent, a sample of whole-blood already collected for 297 in-hospital biochemical analysis or SARS-CoV-2 serology was used for genomic DNA 298 extraction. 299 . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ;

We used a dichotomous category defined among SARS-CoV-2 participants. We 331 have grouped individuals that did not require hospitalization into the control group 332 (participants ascertained through population-based serological prevalence studies that did 333 not have a prior history of hospitalization due to and hospitalized individuals 334 (ascertained at the first hospital admission day) in the case group. Baseline categorical 335 parameters are presented using frequencies (proportions), continuous parameters are 336 presented using mean ± SD. 337

Genome-wide association analyses were conducted using plink. We have 338 conducted two analyses one without any further adjustment and one adjusting for the first 339 four principal components, age, sex, and array type. The threshold for genome-wide 340 significance was set to p <5×10 −8 . Associations with p <1×10 −6 were considered as 341 suggestive and presented as a list of top associated SNPs. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 13 For colocalization analysis we have defined a window spanning 400Kb centered 362 at the most associated variant in all regions classified as having a suggestive association 363 signal. Information on all variants within this region was used for colocalization testing. 364

We have used the R package coloc for colocalization analysis. Briefly, all genes residing 365 in each selected region with their expression quantitative trait loci (eQTL) summary 366 statistics available in GTEx V8.0 were sequentially tested for colocalization with the 367 results obtained for Covid-19 severity association. As reference LD structure we used 368 1000 genomes 2012 European LD matrix (our sample has approximately 80% European 369 ancestry). Colocalization was tested against all 48 tissues available in GTEx V8.0 and 370 against all traits with significant association to the selected variant (as described in the 371 phewas section). We used a threshold of H4 (the posterior probability that a single causal 372 variant, or haplotype, could explain the local association pattern of both tested traits) > 373 0.7 as evidence for significant colocalization. 374 375 Acknowledgements 376

The BRACOVID project received an unrestricted financial support from JBS S.A. 377

Company, Sao Paulo, Brazil and from the general public under the HC-COMVIDA 378 crowdfunding scheme (https://viralcure.org/c/hc). The funds were managed by Fundação 379

Zerbini and Fundação Faculdade de Medicina, respectively. We are thankful for the infra-380 structure support for sample collection provided by the HCFMUSP Covid-19 Study 381

Group. We are also grateful to the Host Genetic Initiative for making their data publicly 382 available (full acknowledgements can be found at 383 https://www.covid19hg.org/acknowledgements/). 384 385

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ;

The authors certify that they have NO affiliations with or involvement in any 387 organization or entity with any financial interest in the subject matter or materials 388 discussed in this manuscript. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. values (red spectrum) for higher H3 than H4. Inner circle represents study/database of 461 trait being colocalized with BRACOVID results. Black: Datasets that satisfy minimum 462 requirements imported from the EBI database of complete GWAS summary data; red: 463 C  H  R  B  P  S  N  P  E  f  f  e  c  t  A  l  l  e  l  e  P  O  R  G  e  n  e  s   1  2  0  5  2  0  8  4  8  9  c  h  r  1  :  2  0  5  2  0  8  4  8  9  :  G  :  A  G  3  .  9  9  E  -0  8  1  .  3  5  1  6  R  B  B  P  5  ,  D  S  T  Y  K  ,  T  M  C  C  2  2  4  5  5  8  4  9  7  9  c  h  r  2  :  4  5  5  8  4  9  7  9  :  T  :  C  C  4  .  0  6  E  -0  7  0  .  7  5  0  9  S  R  B  D  1  4  2  5  6  1  3  3  1  3  c  h  r  4  :  2  5  6  1  3  3  1  3  :  G  :  A  A  3  .  2  1  E  -0 

Patients with Pneumonia in China

COVID-19 Dashboard by the Center for Systems Science and Engineering

Emerging Pandemic Diseases: How We Got to COVID-397 19

Lethal Infectious Diseases as Inborn Errors of Immunity

Toward a Synthesis of the Germ and Genetic Theories

The human genetic determinism of life-threatening 402 infectious diseases: genetic heterogeneity and physiological homogeneity? Hum 403

Genomewide Association Study of Severe Covid-19 with Respiratory Failure

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity (which was not certified by peer review)The copyright holder for this pre this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.06.21264631 doi: medRxiv preprint . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted October 7, 2021. ; https://doi.org/10.1101/2021.10.06.21264631 doi: medRxiv preprint